Health care stocks were leaning lower premarket Monday with the Health Care Select Sector SPDR Fund (XLV) marginally declining and the iShares Biotechnology ETF (IBB) recently down 0.4%.
Sanofi (SNY) said it has entered into binding talks to sell a 50% controlling stake in French life sciences company Opella to CD&R in a deal valuing the company at about 16 billion euros ($17.37 billion). Sanofi shares were 0.9% lower pre-bell.
Ontrak (OTRK) shares were down nearly 3% after the company filed a preliminary prospectus Friday for the sale of up to about 6.5 million common shares that are issuable upon exercise of outstanding public warrants.
Ionis Pharmaceuticals (IONS) shares were up 0.8% after the company said the Committee for Medicinal Products for Human Use has recommended approval of the company and AstraZeneca's (AZN) Wainzua drug to treat hereditary transthyretin-mediated amyloidosis in the European Union.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。